angiotensin ii has been researched along with guanosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amann, K; Brand, S; Mandel, P; Schupp, N; Zimnol, A | 1 |
| Aboud, O; Biedermann, J; Gentleman, SM; Griffin, WS; Mrak, RE; Palmer, QD; Zawada, WM | 1 |
2 other study(ies) available for angiotensin ii and guanosine
| Article | Year |
|---|---|
Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Deoxyguanosine; DNA Damage; DNA Repair; Enzyme Activation; Eplerenone; Guanosine; Heart; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Spin Labels; Spironolactone; Tetrazoles | 2014 |
Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation.
Topics: Aged; Aged, 80 and over; Angiotensin II; Case-Control Studies; Caspase 3; Disease Progression; Dopaminergic Neurons; Female; Guanosine; Humans; Male; NADPH Oxidases; Oxidative Stress; Parkinson Disease; Receptor, Angiotensin, Type 1; Substantia Nigra | 2015 |